5 publications since last update:
- Is next-generation sequencing for rare disease diagnosis worth the cost? User-based approach to evaluation | link
- Clinical utility and cost-effectiveness of BeginNGS newborn screening with genome sequencing and standard newborn screening for serious pediatric genetic diseases: an adaptive, international and comparative clinical trial | link
- The value of extensive and early genomic profiling in cancer care in Sweden | link
- Cost-effectiveness analysis of metagenomic next-generation sequencing versus conventional bacterial culture for postoperative central nervous system infections in the intensive care unit: a prospective pilot study | link
- Data-related and methodological challenges in assessing the cost-effectiveness of traditional and genomic newborn screening programs | link
I’m excited to share some other publications I missed this week. Please let me know. I post these updates every Tuesday, but only if I see a related publication. If you don’t see any updates on Tuesday, assume it was a quiet week for publications in the fields of health economics and genomics.
